CRT 2026
Spotlight
James B. Hermiller, MD, FACC, MSCAI
Director Interventional Cardiology
St. Vincent Medical Group
Indianapolis, Indiana, United States
Disclosure(s): Edwards, Abbott: Consulting Fees (e.g., advisory boards) (Ongoing)
Dean J. Kereiakes, MD, FACC, MSCAI
Chairman, The Christ Hospital Heart and Vascular Institute; Medical Director, The Christ Hospital Research Institute; Professor of Clinical Medicine, The Ohio State University
The Christ Hospital Health Network
Cincinnati, Ohio, United States
Disclosure(s): Ablative Solutions, Inc.: Stock Options [in privately held companies] (Ongoing); CeleCor Therapeutics: Consulting Fees (e.g., advisory boards) (Ongoing); Edwards Lifesciences LLC: Consulting Fees (e.g., advisory boards) (Ongoing); Egg Medical, Inc: Stock Options [in privately held companies] (Ongoing); Elixir Medical Corporation: Consulting Fees (e.g., advisory boards) (Ongoing); Foldax: Consulting Fees (e.g., advisory boards) (Ongoing); OrchestraBiomed: Consulting Fees (e.g., advisory boards) (Ongoing); Shockwave Medical: Consulting Fees (e.g., advisory boards) (Ongoing); Sino Medical Sciences Technology, Inc.: Consulting Fees (e.g., advisory boards) (Ongoing)
David Cox, MD, MSCAI
Interventional Cardiologist
Sanger HVI Charlotte NC
Charlotte, North Carolina, United States
Disclosure(s): No financial relationships to disclose
Rhian E. Davies, DO MS
Interventional Cardiology
WellSpan York Hospital
Annville, Pennsylvania, United States
Disclosure(s): Terumo: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
Morton J. Kern, MD, MSCAI, FACC, FAHA
Interventional Cardiologist
VA Long Beach Health Care System
Long Beach, California, United States
Disclosure(s): Abbott: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Abbott Vascular, Abiomed, ACIST medical, Boston Scientific, Cardialysis BV, CardiacBooster, Kaminari Medical, ReCor Medical, PulseCath, Pie Medical, Sanofi, Siemens Health Care and Medtronic.: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
Kenneth Rosenfield, MD, MHCDS
section head, vascular medicine and intervention
Massachusetts General Hospital
boston, Massachusetts, United States
Disclosure information not submitted.
Eric A. Secemsky, MD, MSc
Director of Vascular Intervention
Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States
Disclosure(s): Abbott, Asahi, BD, Boston Scientific, Conavi, Cook, Cordis, Endovascular Engineering, Evident Vascular, Gore, InfraRedx, Medtronic, Penumbra, Philips, RapidAI, Rampart IC, R3, Regeneron, Shockwave, Siemens, SoniVie, Teleflex, Terumo, Thrombolex, Vent: Consulting Fees (e.g., advisory boards) (Ongoing)
Evan Shlofmitz, DO
Director of Intravascular Imaging
St. Francis Hospital - The Heart Center
Roslyn, New York, United States
Disclosure(s): ABBOTT VASCULAR, ACIST MEDICAL, BOSTON SCIENTIFIC, CHIESI, HEARTFLOW, GENTUITY, MEDTRONIC, PHILIPS, RADIACTION, SHOCKWAVE MEDICAL, TERUMO: Consulting Fees (e.g., advisory boards) (Ongoing); AMGEN, NOVO NORDISK: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
Gerald S. Werner, MD, PhD, FSCAI
Senior Consultant CTO
University Heart Center Frankfurt/Main
Frankfurt am Main, Hessen, Germany
Disclosure(s): No financial relationships to disclose